Li Haochu, Marley Gifty, Ma Wei, Wei Chongyi, Lackey Mellanye, Ma Qingyan, Renaud Françoise, Vitoria Marco, Beanland Rachel, Doherty Meg, Tucker Joseph D
School of Public Health, Shandong University, Jinan, China.
UNC Project-China, Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
AIDS Behav. 2017 Feb;21(2):341-351. doi: 10.1007/s10461-016-1545-0.
Poor adherence remains a major barrier to achieving the clinical and public health benefits of antiretroviral drugs (ARVs). A systematic review and qualitative meta-synthesis was conduct to evaluate how ARV adverse drug reactions may influence ARV adherence. Thirty-nine articles were identified, and 33 reported that ARV adverse drug reactions decreased adherence and six studies found no influence. Visually noticeable adverse drug reactions and psychological adverse reactions were reported as more likely to cause non-adherence compared to other adverse drug reactions. Six studies reported a range of adverse reactions associated with EFV-containing regimens contributing to decreased adherence. Informing HIV-infected individuals about ARV adverse drug reactions prior to initiation, counselling about coping mechanisms, and experiencing the effectiveness of ARVs on wellbeing may improve ARV adherence.
对抗逆转录病毒药物(ARVs)的依从性差仍然是实现其临床和公共卫生效益的主要障碍。我们进行了一项系统综述和定性元分析,以评估ARV药物不良反应如何影响ARV依从性。共识别出39篇文章,其中33篇报告ARV药物不良反应会降低依从性,6项研究未发现有影响。与其他药物不良反应相比,视觉上明显的药物不良反应和心理不良反应更有可能导致不依从。6项研究报告了一系列与含依非韦伦(EFV)方案相关的不良反应,这些不良反应导致依从性下降。在开始治疗前告知HIV感染者ARV药物不良反应、提供应对机制咨询以及让他们体验ARV对健康的有效性,可能会提高ARV依从性。